Detalhe da pesquisa
1.
Long-term outcomes of R-CEOP show curative potential in patients with DLBCL and a contraindication to anthracyclines.
Blood Adv
; 5(5): 1483-1489, 2021 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33683338
2.
Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-kappaB, p53, bax, and p27 levels.
Mol Cancer Ther
; 7(4): 749-58, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18375822
3.
Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma.
Leuk Res
; 30(4): 449-57, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16183118
4.
Randomized phase III study of fludarabine phosphate versus cyclophosphamide, vincristine, and prednisone in patients with recurrent low-grade non-Hodgkin's lymphoma previously treated with an alkylating agent or alkylator-containing regimen.
J Clin Oncol
; 20(24): 4649-54, 2002 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12488409
5.
Treatment of elderly Hodgkin's lymphoma patients with a novel 5-drug regimen (ODBEP): a phase II study.
Leuk Lymphoma
; 43(7): 1395-402, 2002 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12389619
6.
The spectrum of lymphoma with 8q24 aberrations: a clinical, pathological and cytogenetic study of 87 consecutive cases.
Leuk Lymphoma
; 45(3): 519-28, 2004 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15160914
7.
Cytogenetic analysis in mantle cell lymphoma: a review of 214 cases.
Leuk Lymphoma
; 43(4): 783-91, 2002 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12153165
8.
Targeting the proapoptotic factor Bcl-2 in non-Hodgkin's lymphoma.
Oncology (Williston Park)
; 18(13 Suppl 10): 25-31, 2004 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-15651174
9.
Plasma protein binding, lipoprotein distribution and uptake of free and lipid-associated BCL-2 antisense oligodeoxynucleotides (G3139) in human melanoma cells.
Int J Pharm
; 241(1): 57-64, 2002 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-12086721
10.
International Prognostic Score in advanced-stage Hodgkin's lymphoma: altered utility in the modern era.
J Clin Oncol
; 30(27): 3383-8, 2012 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22869887
11.
A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172).
Leuk Lymphoma
; 52(3): 394-9, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21323520
12.
Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma.
J Clin Oncol
; 26(32): 5165-9, 2008 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-18838711
13.
Oblimersen Bcl-2 antisense: facilitating apoptosis in anticancer treatment.
Antisense Nucleic Acid Drug Dev
; 12(3): 193-213, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12162702
14.
Cytogenetic findings in reactive lymphoid hyperplasia: significance of non-clonal t(3;14) and t(3;22).
Am J Hematol
; 70(2): 133-8, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12111786
15.
Multicolour fluorescence in situ hybridization analysis of t(14;18)-positive follicular lymphoma and correlation with gene expression data and clinical outcome.
Br J Haematol
; 122(5): 745-59, 2003 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12930384
16.
Delineation of a minimal region of deletion at 6q16.3 in follicular lymphoma and construction of a bacterial artificial chromosome contig spanning a 6-megabase region of 6q16-q21.
Genes Chromosomes Cancer
; 40(1): 60-5, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15034870